The test is intended for adults 55 and older in the United States who are showing signs or symptoms of cognitive decline.

This comes at the heel of FDA's nod for Fujirebio Diagnostics' blood test Lumipulse in May, the first such device to get ...

Cancer is a challenging enough diagnosis, but many patients are dealt a second blow, even as they heal: "chemo brain." ...

Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical ...

A Swedish-led study validated a self-administered digital cognitive test (BioCog) in primary care, showing it can accurately ...

The Alzheimer’s Association of the Hudson Valley has received a $10,000 donation from Emery & Webb, Inc. The donation will be ...

More than 300 people walked to end Alzheimer’s in Gastonia Saturday. The Western Carolina Chapter of the Alzheimer’s ...

Today, over 2000 people gathered at Buffalo’s Outer Harbor for the 2025 Walk to End Alzheimer’s, coming together to raise ...

Biogen Inc has shown "exceptionally persuasive" evidence that its experimental Alzheimer's disease drug is effective, U.S. Food and Drug Administration staff said on Wednesday, elevating its chances ...

The prevalence of Alzheimer disease (AD) is approximately two times higher in African Americans (AA) compared to White/European-ancestry (EA) individuals living in the U.S. Some of this is due to ...

New Blood-Based Assay Delivers Unparalleled Sensitivity and Specificity to enable the next generation of assay development.

Noah Haswell, Beaver County Radio News (New Sewickley Township, PA) The Alzheimer’s Association is encouraging residents of ...